Home » Newsletters » BioWorld

BioWorld

April 10, 1992

View Archived Issues

ROBERTS ACQUIRES RIGHTS TO TWO DRUGS

GLIATECH FILES INITIAL PUBLIC OFFERING

PRELIMINARY DATA ON HEPATITIS B THERAPY

FUTURE MEDICAL ACQUIRES MAB TECHNOLOGY

NPS RAISES $5 MILLION IN VENTURE ROUND

INCYTE SEPSIS TEST CHALLENGES CENTOXIN

ROBUST DAY FOR BIOTECH STOCKS

PROLEUKIN APPROVED IN AUSTRIA

BAXTER SETS BLOOD SUBSTITUTE TRIAL

CATVAX MOVING INTO THE CLINIC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...